Abstract
Purpose Recent trends in US healthcare have seen growing consolidation of healthcare providers, including radiology groups, with fewer and larger radiology groups. We assessed recent trends and characteristics in radiology group network market share (NMS) across the US among Medicare beneficiaries.
Methods Using freely available datasets CareSet DocGraph Hop Teaming, Medicare Physician Compare, and Medicare Physician and Other Supplier Public Use File (PUF), all radiologists were identified and associated to group practices annually between 2014 and 2017. Radiology groups outside the US, not present in all three databases, or with only one radiologist were excluded. The annual frequency of radiological exams performed was determined from the PUF and used to calculate the percentage of magnetic resonance and computed tomography (MR/CT) imaging performed as well as the number of beneficiaries undergoing MR/CT per radiology group. Physician referrers without evaluation and management codes for office visits in the PUF file were excluded from the DocGraph file. Provider connections were geospatially mapped and plotted. The percentage of radiology group NMS was calculated as the number of patients a group received, divided by the total number of potential and actual connections, and multiplied by 100. Univariate analysis of radiology group NMS was performed against a variety of characteristics and compared using Kruskal–Wallis and Dunn tests, as appropriate. Univariate linear regression was used to assess the association between NMS and calendar year, as well as average wait time and calendar year. Multivariate linear regression was used to model the radiology group cumulative normalized percentile NMS, with multiple predictors for the year 2017.
Results Between 2014 and 2017, 1,764 unique radiology groups were identified, representing 17,879 radiologists in 2014, 18,143 radiologists in 2015, 20,915 radiologists in 2016, and 22,187 radiologists in 2017, with an average NMS per group for 2014 of 14.8%, 2015 of 14.5%, 2016 of 13.6%, and 2017 of 13.1%, demonstrating a small but statistically significant negative trend over four years (2014–2017), with a 0.6% decrease per year (P < 0.001). Average day weight across years (2014–2017) demonstrated a slight upward trend, with a 0.3% increase per year. The yearly percentage of MR/CT studies across all groups was 24.6–26.6%, with the most performed studies being chest radiography, mammography, and CT of the head without contrast. Univariate analysis of radiology group NMS was not significantly different between academic and nonacademic groups for all years (P > 0.05) but was significantly different for radiology-only versus multispecialty groups across all years (P < 0.05). Multivariate linear regression on 2017 data demonstrated statistically significant independent negative predictors for NMS including larger group size (50–99, >=100), higher practice MR/CT imaging percentage, and South location, while the increasing log of the number of beneficiaries undergoing MR/CT was a positive predictor, with an adjusted R-squared of 0.56 (all P < 0.01).
Conclusions Among Medicare beneficiaries from 2014 to 2017, radiology group NMS (mean 14%, median 9.0%, IQR 4–19.2%), slightly decreased over time by 0.6% per year, despite occurring during a period of widespread practice consolidation. The negative predictors for NMS at the group level included larger group size, South region, increased average wait time, and higher MR/CT imaging percentage, while the positive predictor was the increased number of beneficiaries undergoing MR/CT. Of these predictors, radiology groups are most likely to increase NMS by decreasing average wait times.
Highlights
Radiology group network market share (NMS) of Medicare beneficiaries is remarkably stable (mean 14%, median 9.0%, IQR 4–19.2%), with a statistically significant but small negative trend over four years (2014–2017), with a 0.6% increase per year.
Multivariate linear regression demonstrated that a higher percentage of magnetic resonance and computed tomography (MR/CT) imaging, group size (50–99, >= 100), South region, and longer average wait time are all negative predictors of NMS, and the only significant positive predictor of NMS is the increasing log number of beneficiaries undergoing MR/CT (all P < 0.05).
Of all predictors, average wait time is arguably the most malleable for a radiology group and should be closely monitored and reduced, as this may increase NMS. Additionally, having a diverse practice of services may offer additional opportunities to retain patients and grow NMS. In spite of radiology group consolidation, with the continued shift to value-based care, radiology groups need to be aware that the radiology market remains highly fragmented.
Source code for this project is available (https://github.com/apyrros/docgraph/) and can be freely run in Google Colab using Google Drive to store the necessary files.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Research reported in this publication is part of MIDRC (The Medical Imaging Data Resource Center) and was made possible by the National Institute of Biomedical Imaging and Bioengineering (NIBIB) of the National Institutes of Health under contracts 75N92020C00008 and 75N92020C00021.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
E-mail addresses: ayis{at}ayis.org Ayis Pyrros, MD, bfornelli{at}choosehmc.com Brian Fornelli, MS, jrodr76{at}uic.edu Jorge Mario Rodríguez-Fernández, MD, sborstelmannmd{at}gmail.com Stephen M. Borstelmann, MD, nasir.siddiqui{at}dupagemd.com, Nasir Siddiqui, MD, BillG{at}uic.edu,William Galanter, MD, Phd
The author(s) declare(s) that they had full access to all the data in this study and the author(s) take(s) complete responsibility for the integrity of the data and the accuracy of the data analysis.
Funding: Research reported in this publication is part of MIDRC (The Medical Imaging Data Resource Center) and was made possible by the National Institute of Biomedical Imaging and Bioengineering (NIBIB) of the National Institutes of Health under contracts 75N92020C00008 and 75N92020C00021.
Data Availability
All data produced in the present study are available upon reasonable request to the authors
